跳转至内容
Merck

810223P

Avanti

C12-NBD Glucosyl Ceramide

Avanti Research - A Croda Brand

别名:

N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-β1-1′-sphingosine

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C42H71N5O11
分子量:
822.04
分類程式碼代碼:
12352211
NACRES:
NA.25

化驗

>99% (TLC)

形狀

powder

包裝

pkg of 1 × 1 mg (810223P-1MG)
pkg of 1 × 250 μg (810223P-250ug)

製造商/商標名

Avanti Research - A Croda Brand

運輸包裝

dry ice

儲存溫度

−20°C

應用

C12-NBD Glucosyl Ceramide is suitable for liposome preparation.

生化/生理作用

Glucosyl ceramide (GlcCer) is produced by GlcCer synthase from ceramide in the cytosolic membranes of Golgi. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids.

包裝

5 mL Amber Glass Screw Cap Vial (810223P-1MG)
5 mL Amber Glass Screw Cap Vial (810223P-250ug)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

The effects of chemically synthesized saposin C on glucosylceramide-beta-glucosidase
Yoneshige A, et al.
Clinical Biochemistry, 48(16-17), 1177-1180 (2015)
Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide
D?Angelo G, et al.
Nature, 449(7158), 62-62 (2007)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门